Angela L Wang, Costantino Iadecola, Gang Wang. New generations of dihydropyridines for treatment of hypertension[J]. Journal of Geriatric Cardiology, 2017, 14(1): 67-72. DOI: 10.11909/j.issn.1671-5411.2017.01.006
Citation: Angela L Wang, Costantino Iadecola, Gang Wang. New generations of dihydropyridines for treatment of hypertension[J]. Journal of Geriatric Cardiology, 2017, 14(1): 67-72. DOI: 10.11909/j.issn.1671-5411.2017.01.006

New generations of dihydropyridines for treatment of hypertension

  • Since the calcium channel blocker (CCB) has become one of the most prescribed agents for antihypertensive monotherapy in the world, this brief review will focus on the recent research and development of the dihydropyridine (DHP) CCB, addressing pharmacological me-chanisms for the clinical efficacy of the third and fourth generations of the DHP CCBs, especially on their possible central mechanisms underlying lowering blood pressure.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return